QTL Biodetection
LLC develops and markets bioassays that deliver superior sensitivity,
specificity, and and speed in simple-to-use formats with low total cost of
detection. The Company delivers enzyme activity and protein binding
assays for the pharmaceutical and life sciences markets, and Biosensor
Systems for first responders, medical triage personnel, and military users.
Bioassay products are available for the detection of viruses, toxins,
bacteria, proteins, hormones, nucleic acids, and other biological compounds.
QTL's novel technologies integrate its expertise in chemistry, molecular and
cell biology, and instrumentation.
Current joint ventures include the:
Biosensor 2200R
Medical Biosensor
CMS and mCMS air monitoring systems